Sympathetic Activation in Hypertensive Chronic Kidney Disease – A Stimulus for Cardiac Arrhythmias and Sudden Cardiac Death?

Sympathetic Activation in Hypertensive Chronic Kidney Disease – A Stimulus for Cardiac Arrhythmias and Sudden Cardiac Death?

Studies have revealed a robust and independent correlation between chronic kidney disease (CKD) and cardiovascular (CV) events, including death, heart failure, and myocardial infarction. Recent clinical trials extend this range of adverse CV events, including malignant ventricular arrhythmias and su...

Bibliografski detalji
Glavni autori:	Márcio Galindo Kiuchi, Jan K. Ho, Janis Marc Nolde, Leslie Marisol Lugo Gavidia, Revathy Carnagarin, Vance B. Matthews, Markus P. Schlaich
Format:	Članak
Jezik:	English
Izdano:	Frontiers Media S.A. 2020-01-01
Serija:	Frontiers in Physiology
Teme:	chronic kidney disease sympathetic nervous system hypertension left ventricular hypertrophy sudden cardiac death ventricular remodeling
Online pristup:	https://www.frontiersin.org/article/10.3389/fphys.2019.01546/full

Slični predmeti

Machine learning powered tools for automated analysis of muscle sympathetic nerve activity recordings
od: Janis M. Nolde, i dr.
Izdano: (2021-08-01)

Sympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation
od: Revathy Carnagarin, i dr.
Izdano: (2019-01-01)

The molecular basis for the neutral effect of renal denervation in patients with chronic heart failure not responding to cardiac resynchronisation therapy – a perspective
od: Márcio Kiuchi, i dr.
Izdano: (2019-12-01)

The effect of bilateral cardiac sympathetic denervation for refractory ventricular tachycardia in ischemic cardiomyopathy
od: Yuko Miki, i dr.
Izdano: (2020-06-01)

Chronic kidney disease and risk factors responsible for sudden cardiac death: a whiff of hope?
od: Márcio G. Kiuchi, i dr.
Izdano: (2016-03-01)

Focusing on Sodium Glucose Cotransporter-2 and the Sympathetic Nervous System: Potential Impact in Diabetic Retinopathy
od: Lakshini Y. Herat, i dr.
Izdano: (2018-01-01)

Microvascular changes at different stages of chronic kidney disease
od: Dennis Kannenkeril, i dr.
Izdano: (2021-02-01)

Arrhythmic Risk Profile and Outcomes of Patients Undergoing Cardiac Sympathetic Denervation for Recurrent Monomorphic Ventricular Tachycardia After Ablation
od: Veronica Dusi, i dr.
Izdano: (2021-01-01)

Device-based approaches for renal nerve ablation for hypertension and beyond
od: Alicia Ann Thorp, i dr.
Izdano: (2015-07-01)

Circulating platelet‐derived extracellular vesicles correlate with night‐time blood pressure and vascular organ damage and may represent an integrative biomarker of vascular health
od: Leslie Marisol Lugo‐Gavidia, i dr.
Izdano: (2022-06-01)

Sudden Cardiac Death and Idiopathic Ventricular Arrhythmias
od: Vries Lennart de, i dr.
Izdano: (2015-12-01)

Transgenic models of cardiac arrhythmias and sudden death
od: Carol Ann eRemme
Izdano: (2013-03-01)

The Schlager mouse as a model of altered retinal phenotype
od: Lakshini Y Herat, i dr.
Izdano: (2020-01-01)

Evidence of Ventricular Arrhythmogenicity and Cardiac Sympathetic Hyperinnervation in Early Cirrhotic Cardiomyopathy
od: Shin-Huei Liu, i dr.
Izdano: (2021-12-01)

Efficacy and safety of cardiac sympathetic denervation for refractory ventricular arrhythmias: Experience of a Colombian hospital
od: Nicolas Arredondo-Mora, i dr.
Izdano: (2024-03-01)

Cardiac Sympathetic Denervation in Channelopathies
od: Veronica Dusi, i dr.
Izdano: (2019-03-01)

Sympathetic Activation and Arrhythmogenesis after Myocardial Infarction: Where Do We Stand?
od: Konstantinos C. Zekios, i dr.
Izdano: (2021-05-01)

Aerobic exercise training in heart failure: impact on sympathetic hyperactivity and cardiac and skeletal muscle function
od: P.C. Brum, i dr.
Izdano: (2011-09-01)

Aerobic exercise training in heart failure: impact on sympathetic hyperactivity and cardiac and skeletal muscle function
od: P.C. Brum, i dr.
Izdano: (2011-09-01)

Effects of Renal Denervation on Sympathetic Activation, Blood Pressure and Glucose Metabolism in Patients with Resistant Hypertension
od: Markus Peter Schlaich, i dr.
Izdano: (2012-02-01)

Optogenetic Termination of Cardiac Arrhythmia: Mechanistic Enlightenment and Therapeutic Application?
od: Philipp Sasse, i dr.
Izdano: (2019-06-01)

Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines
od: D. S. Lebedev, i dr.
Izdano: (2021-08-01)

Case Report: The unrelenting journey—successful resolution of catecholaminergic polymorphic ventricular tachycardia (CPVT) through right cardiac sympathetic denervation in a teenager after left cardiac sympathetic denervation
od: Hei-To Leung, i dr.
Izdano: (2024-12-01)

Supine blood pressure—A clinically relevant determinant of vascular target organ damage in hypertensive patients
od: Janis M. Nolde, i dr.
Izdano: (2021-01-01)

Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmia in Continuous-Flow Left Ventricular Assist Device
od: Peter P. Vlismas, MD, i dr.
Izdano: (2021-03-01)

Comments on 2015 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
od: Ali Deniz, i dr.
Izdano: (2016-02-01)

Editorial: The role of sex in cardiac arrhythmias and sudden cardiac death
od: Matias E. Pollevick, i dr.
Izdano: (2023-03-01)

Renal sympathetic denervation assisted treatment of electrical storm due to polymorphic ventricular tachycardia in a patient with cathecolaminergic polymorphic ventricular tachycardia
od: Tolga Aksu, i dr.
Izdano: (2017-07-01)

Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome
od: Alicia A. Thorp, i dr.
Izdano: (2015-01-01)

Cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia in the light of the medical situation in Japan
od: Masayoshi Mori, i dr.
Izdano: (2024-08-01)

Acute hemodynamics of cardiac sympathetic denervation
od: Kunal Sinkar, i dr.
Izdano: (2020-11-01)

Central sympathetic activation and arrhythmogenesis during acute myocardial infarction: modulating effects of endothelin-B receptors
od: Theofilos M Kolettis, i dr.
Izdano: (2015-02-01)

Sudden cardiac death in patients with nonischemic cardiomyopathy
od: Brian P. Betensky, i dr.
Izdano: (2014-01-01)

Homocysteine predicts vascular target organ damage in hypertension and may serve as guidance for first‐line antihypertensive therapy
od: Revathy Carnagarin, i dr.
Izdano: (2021-07-01)

Reclassification of Heart Failure with Preserved Ejection Fraction Following Cardiac Sympathetic Nervous System Activation: A New Cutoff Value of 58%
od: Toshihiko Goto, i dr.
Izdano: (2022-06-01)

Alcohol Ablation for Cardiac Arrhythmias: Is it Time to Drown the Arrhythmias?
od: Anandaraja Subramanian, MD, DM, FCE
Izdano: (2012-07-01)

QUANTIFICATION OF ELECTROCARDIOGRAM RHYTHMICITY TO DETECT LIFE THREATENING CARDIAC ARRHYTHMIAS USING SPECTRAL ENTROPY
od: CHANDRAKAR KAMATH
Izdano: (2013-10-01)

RISK STRATIFICATION OF SUDDEN CARDIAC DEATH IN EARLY REPOLARIZATION SYNDROME
od: Shpak N. V., i dr.
Izdano: (2019-11-01)

Effect of SGLT-2 inhibitors on arrhythmia events: insight from an updated secondary analysis of > 80,000 patients (the SGLT2i—Arrhythmias and Sudden Cardiac Death)
od: Jia Liao, i dr.
Izdano: (2024-02-01)

Change in sympathetic nerve firing pattern associated with dietary weight loss in the metabolic syndrome
od: Elisabeth Annie Lambert, i dr.
Izdano: (2011-08-01)